Sign inGet started

TAGLIAFERRI MARY

Insider CIK 1323304 · YMAB Director · RYZB Director · IAM Director · ENZ Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IAM Iambic Therapeutics, Inc. A Award deriv2026-10-142026-10-1620,300— $020,300SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2024-06-112024-06-1314,545— $014,545SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2024-06-112024-06-133,495— $08,155SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award deriv2024-03-122024-03-1427,900— $027,900SEC↗
YMAB Y-mAbs Therapeutics, Inc. A Award2024-03-122024-03-144,660— $04,660SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2740,848— $00SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2773,731— $00SEC↗
ENZ ENZO BIOCHEM INC A Award2024-01-312024-02-0279,365— $0312,383SEC↗
ENZ ENZO BIOCHEM INC A Award2023-02-092023-02-1375,188— $0155,917SEC↗
ENZ ENZO BIOCHEM INC A Award2022-07-122022-07-1441,666— $080,729SEC↗
ENZ ENZO BIOCHEM INC A Award2022-04-272022-04-2939,063— $039,063SEC↗
ENZ ENZO BIOCHEM INC A Award deriv2021-01-112021-01-1377,101— $077,101SEC↗